Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study evaluating umbilical cord/placenta-derived mesenchymal stem cells for severe aplastic anemia. Current status of the trial is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Shandong University | Conditions: Aplastic Anemia | Phase 2 | Status: UNKNOWN